K Pharma,Inc. Statistics
Want to see JP:4896 full AI Analyst Report?
K Pharma,Inc. (4896) Stock Statistics & Valuation Metrics
Total Valuation
K Pharma,Inc. has a market cap or net worth of JPY 7.15B. The enterprise value is JPY 7.25B.
- Market Cap
- JPY 7.15B
- Enterprise Value
- JPY 7.25B
Share Statistics
K Pharma,Inc. has 11,622,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 11,622,600
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
K Pharma,Inc.’s return on equity (ROE) is -0.78 and return on invested capital (ROIC) is -32.28%.
- Return on Equity (ROE)
- -0.78
- Return on Assets (ROA)
- -0.34
- Return on Invested Capital (ROIC)
- -32.28%
- Return on Capital Employed (ROCE)
- -0.32
- Revenue Per Employee
- 0
- Profits Per Employee
- -49.66M
- Employee Count
- 20
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of K Pharma,Inc. is -7.63. K Pharma,Inc.’s PEG ratio is 0.42.
- PE Ratio
- -7.63
- PS Ratio
- 0.00
- PB Ratio
- 10.28
- Price to FCF
- -8.56
- Price to Operating Cash Flow
- -8.66
- PEG Ratio
- 0.42
Income Statement
In the last 12 months, K Pharma,Inc. had revenue of 0 and earned -993.23M in profits. Earnings per share was -85.59.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -916.06M
- Pretax Income
- -990.50M
- Net Income
- -993.23M
- EBITDA
- -983.19M
- Earnings Per Share (EPS)
- -85.59
Cash Flow
In the last 12 months, operating cash flow was -918.00M and capital expenditures -11.19M, giving a free cash flow of -929.19M billion.
- Operating Cash Flow
- -918.00M
- Free Cash Flow
- -929.19M
- Free Cash Flow per Share
- -79.95
Dividends & Yields
K Pharma,Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -11.79%
- Earnings Yield
- -13.21%
Stock Price Statistics
- Beta
- 0.87
- 52-Week Price Change
- 4.15%
- 50-Day Moving Average
- 759.04
- 200-Day Moving Average
- 744.86
- Relative Strength Index (RSI)
- 24.18
- Average Volume (3m)
- 21.77K
Important Dates
K Pharma,Inc. upcoming earnings date is Nov 13, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 13, 2026
- Ex-Dividend Date
- ―
Financial Position
K Pharma,Inc. as a current ratio of 28.41, with Debt / Equity ratio of 118.54%
- Current Ratio
- 28.41
- Quick Ratio
- 28.29
- Debt to Market Cap
- 0.20
- Net Debt to EBITDA
- 1.31
- Interest Coverage Ratio
- -125.30
Taxes
In the past 12 months, K Pharma,Inc. has paid 2.73M in taxes.
- Income Tax
- 2.73M
- Effective Tax Rate
- -0.00
Enterprise Valuation
K Pharma,Inc. EV to EBITDA ratio is -6.99, with an EV/FCF ratio of -7.70.
- EV to Sales
- 0.00
- EV to EBITDA
- -6.99
- EV to Free Cash Flow
- -7.70
- EV to Operating Cash Flow
- -7.79
Balance Sheet
K Pharma,Inc. has JPY 2.71B in cash and marketable securities with JPY 1.65B in debt, giving a net cash position of JPY 1.06B billion.
- Cash & Marketable Securities
- JPY 2.71B
- Total Debt
- JPY 1.65B
- Net Cash
- JPY 1.06B
- Net Cash Per Share
- JPY 91.05
- Tangible Book Value Per Share
- JPY 87.41
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for K Pharma,Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -20.34%
Scores
- Smart Score
- ―
- AI Score
- 40.85
